Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (Q24534620): Difference between revisions
Jump to navigation
Jump to search
Added [de] description: wissenschaftlicher Artikel (veröffentlicht in Dezember 2005), #quickstatements |
Research Bot (talk | contribs) Added reference to claim: number of pages (P1104): 9, batch #105231 |
||||||||||||||
| (19 intermediate revisions by 13 users not shown) | |||||||||||||||
| label / en-gb | label / en-gb | ||||||||||||||
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 | |||||||||||||||
| label / ast | label / ast | ||||||||||||||
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 | |||||||||||||||
| description / hy | description / hy | ||||||||||||||
գիտական հոդված | 2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված | ||||||||||||||
| description / ar | description / ar | ||||||||||||||
مقالة علمية (نشرت في ديسمبر 2005) | |||||||||||||||
| description / ko | description / ko | ||||||||||||||
2005년 논문 | |||||||||||||||
| description / tg-cyrl | description / tg-cyrl | ||||||||||||||
мақолаи илмӣ | |||||||||||||||
| description / ca | description / ca | ||||||||||||||
article científic | |||||||||||||||
| description / bg | description / bg | ||||||||||||||
научна статия | |||||||||||||||
| description / es | description / es | ||||||||||||||
artículo científico publicado en 2005 | |||||||||||||||
| description / lt | description / lt | ||||||||||||||
mokslinis straipsnis | |||||||||||||||
| description / vi | description / vi | ||||||||||||||
bài báo khoa học | |||||||||||||||
| description / ru | description / ru | ||||||||||||||
научная статья | |||||||||||||||
| description / ast | description / ast | ||||||||||||||
artículu científicu espublizáu en 2005 | |||||||||||||||
| description / ka | description / ka | ||||||||||||||
სამეცნიერო სტატია | |||||||||||||||
| description / zh-my | description / zh-my | ||||||||||||||
2005年论文 | |||||||||||||||
| description / sq | description / sq | ||||||||||||||
artikull shkencor | |||||||||||||||
| description / sr-ec | description / sr-ec | ||||||||||||||
научни чланак | |||||||||||||||
| description / he | description / he | ||||||||||||||
מאמר מדעי | |||||||||||||||
| description / tg | description / tg | ||||||||||||||
мақолаи илмӣ | |||||||||||||||
| description / nan | description / nan | ||||||||||||||
2005 nî lūn-bûn | |||||||||||||||
| description / sv | description / sv | ||||||||||||||
vetenskaplig artikel | |||||||||||||||
| description / zh-hant | description / zh-hant | ||||||||||||||
2005年論文 | |||||||||||||||
| description / sr-el | description / sr-el | ||||||||||||||
naučni članak | |||||||||||||||
| description / eo | description / eo | ||||||||||||||
scienca artikolo | |||||||||||||||
| description / yue | description / yue | ||||||||||||||
2005年論文 | |||||||||||||||
| description / zh-hans | description / zh-hans | ||||||||||||||
2005年论文 | |||||||||||||||
| description / nn | description / nn | ||||||||||||||
vitskapeleg artikkel | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
artigo científico (publicado na 2005) | |||||||||||||||
| description / hu | description / hu | ||||||||||||||
tudományos cikk | |||||||||||||||
| description / zh-hk | description / zh-hk | ||||||||||||||
2005年論文 | |||||||||||||||
| description / et | description / et | ||||||||||||||
teaduslik artikkel | |||||||||||||||
| description / zh-tw | description / zh-tw | ||||||||||||||
2005年論文 | |||||||||||||||
| description / oc | description / oc | ||||||||||||||
article scientific | |||||||||||||||
| description / el | description / el | ||||||||||||||
επιστημονικό άρθρο | |||||||||||||||
| description / tr | description / tr | ||||||||||||||
bilimsel makale | |||||||||||||||
| description / zh-cn | description / zh-cn | ||||||||||||||
2005年论文 | |||||||||||||||
| description / nb | description / nb | ||||||||||||||
vitenskapelig artikkel | |||||||||||||||
| description / zh-mo | description / zh-mo | ||||||||||||||
2005年論文 | |||||||||||||||
| description / gl | description / gl | ||||||||||||||
artigo científico | |||||||||||||||
| description / pl | description / pl | ||||||||||||||
artykuł naukowy | |||||||||||||||
| description / th | description / th | ||||||||||||||
บทความทางวิทยาศาสตร์ | |||||||||||||||
| description / tl | description / tl | ||||||||||||||
artikulong pang-agham | |||||||||||||||
| description / ro | description / ro | ||||||||||||||
articol științific | |||||||||||||||
| description / zh-sg | description / zh-sg | ||||||||||||||
2005年论文 | |||||||||||||||
| description / uk | description / uk | ||||||||||||||
наукова стаття, опублікована в грудні 2005 | |||||||||||||||
| description / zh | description / zh | ||||||||||||||
2005年论文 | |||||||||||||||
| description / ja | description / ja | ||||||||||||||
2005年の論文 | |||||||||||||||
| description / wuu | description / wuu | ||||||||||||||
2005年论文 | |||||||||||||||
| description / fi | description / fi | ||||||||||||||
tieteellinen artikkeli | |||||||||||||||
| description / bn | description / bn | ||||||||||||||
২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ | |||||||||||||||
| description / fa | description / fa | ||||||||||||||
مقالهٔ علمی | |||||||||||||||
| description / ur | description / ur | ||||||||||||||
سائنسی مضمون | |||||||||||||||
| description / hyw | description / hyw | ||||||||||||||
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած | |||||||||||||||
| Property / PubMed publication ID: 16304152 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / PMC publication ID: 1315929 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / DOI: 10.1128/AAC.49.12.4911-4919.2005 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / instance of: scholarly article / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / title | |||||||||||||||
| Property / title: Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English) / rank | |||||||||||||||
| Property / original language of film or TV show | |||||||||||||||
| Property / original language of film or TV show: English / rank | |||||||||||||||
| Property / published in: Antimicrobial Agents and Chemotherapy / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / volume: 49 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / issue: 12 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / publication date | |||||||||||||||
| |||||||||||||||
| Property / publication date: December 2005 / rank | |||||||||||||||
| Property / page(s) | |||||||||||||||
| Property / page(s): 4911-9 / rank | |||||||||||||||
| Property / author name string: Julie M Strizki / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string | |||||||||||||||
| Property / author name string: Cecile Tremblay / rank | |||||||||||||||
| Property / author name string: Cecile Tremblay / qualifier | |||||||||||||||
| Property / author name string: Serena Xu / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Lisa Wojcik / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Nicole Wagner / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Waldemar Gonsiorek / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: R William Hipkin / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Chuan-Chu Chou / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Catherine Pugliese-Sivo / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Yushi Xiao / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Jayaram R Tagat / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Kathleen Cox / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Tony Priestley / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Steve Sorota / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Wei Huang / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Martin Hirsch / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Gregory R Reyes / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / author name string: Bahige M Baroudy / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Acquired QT interval prolongation and HERG: implications for drug discovery and development / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Acquired QT interval prolongation and HERG: implications for drug discovery and development / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Resistance to enfuvirtide, the first HIV fusion inhibitor / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Resistance to enfuvirtide, the first HIV fusion inhibitor / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Protein design of an HIV-1 entry inhibitor / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Protein design of an HIV-1 entry inhibitor / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: HIV-1 membrane fusion: targets of opportunity / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: HIV-1 membrane fusion: targets of opportunity / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 27 September 2017
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 29 November 2018
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 29 November 2018
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 29 November 2018
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. / reference | |||||||||||||||
stated in: PubMed Central reference URL: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1315929 retrieved: 29 November 2018
| |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Chemokine receptors and HIV entry / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work: Chemokine receptors and HIV entry / reference | |||||||||||||||
stated in: PubMed reference URL: https://pubmed.ncbi.nlm.nih.gov/16304152 retrieved: 12 December 2020
based on heuristic: inferred from PubMed ID database lookup | |||||||||||||||
| Property / publication date | |||||||||||||||
1 December 2005
| |||||||||||||||
| Property / publication date: 1 December 2005 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / publication date: 1 December 2005 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / title | |||||||||||||||
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English) | |||||||||||||||
| Property / title: Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / title: Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English) / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / page(s) | |||||||||||||||
4911-4919 | |||||||||||||||
| Property / page(s): 4911-4919 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / page(s): 4911-4919 / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / language of work or name | |||||||||||||||
| Property / language of work or name: English / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / ResearchGate publication ID | |||||||||||||||
| Property / ResearchGate publication ID: 7464951 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Cécile Tremblay / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author: Cécile Tremblay / qualifier | |||||||||||||||
| Property / author: Cécile Tremblay / qualifier | |||||||||||||||
object named as: Cecile Tremblay | |||||||||||||||
| Property / author: Cécile Tremblay / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 16304152 retrieved: 5 July 2017
| |||||||||||||||
| Property / number of pages | |||||||||||||||
9
| |||||||||||||||
| Property / number of pages: 9 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / number of pages: 9 / reference | |||||||||||||||
Latest revision as of 03:36, 17 November 2022
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 |
scientific article |
Statements
1 reference
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English)
1 reference
Cecile Tremblay
1 reference
Julie M Strizki
1 reference
Serena Xu
1 reference
Lisa Wojcik
1 reference
Nicole Wagner
1 reference
Waldemar Gonsiorek
1 reference
R William Hipkin
1 reference
Chuan-Chu Chou
1 reference
Catherine Pugliese-Sivo
1 reference
Yushi Xiao
1 reference
Jayaram R Tagat
1 reference
Kathleen Cox
1 reference
Tony Priestley
1 reference
Steve Sorota
1 reference
Wei Huang
1 reference
Martin Hirsch
1 reference
Gregory R Reyes
1 reference
Bahige M Baroudy
1 reference
1 December 2005
1 reference
1 reference
4911-4919
1 reference
Identifiers
1 reference
1 reference
1 reference